Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02015910 · ClinicalTrials.gov registry record · Phase 4
Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
A Phase 4 study, sponsored by Georgetown University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT02015910 is a Phase 4 study that was terminated before completion, run by Georgetown University. The registered enrollment target is 1 participants.
The verdict
NCT02015910, a Phase 4 study, was terminated before completion, sponsored by Georgetown University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the rate of healing as well as percent of wounds healed in Type II diabetic patients with chronic foot ulcerations receiving sitagliptin versus placebo. The hypothesis for this study is that subjects receiving daily doses of sitagliptin in combination with their regular antihyperglycemic medications will result in increased healing rates as well as a greater number of healed wounds as compared to subjects receiving placebo and their regular antihyperglycemic medications.
Interventions
- DRUG Placebo
- DRUG Sitagliptin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02015910
The ClinicalTrials.gov registry entry for NCT02015910 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02015910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02015910 about?
NCT02015910 is a clinical study titled "Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers". The primary objective of this study is to compare the rate of healing as well as percent of wounds healed in Type II diabetic patients with chronic foot ulcerations receiving sitagliptin versus placebo. The hypothesis for this study is that subjects receiving daily doses of sitagliptin in combinati...
What is the current status of trial NCT02015910?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2014-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02015910?
The interventions under investigation include: Placebo (DRUG), Sitagliptin (DRUG).
Who is sponsoring clinical trial NCT02015910?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.